- $121.93bn
- $140.83bn
- £32.67bn
- 98
- 63
- 99
- 99
REG - GlaxoSmithKline PLC - GSK introduces Haleon to investors
AnnouncementREG - GlaxoSmithKline PLC - GSK RSV maternal vaccine candidate further update
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Canada Approval For Medicago GSK Covid-19 Vaccine
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK Consumer Healthcare to be called Haleon
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK gives update on RSV maternal vaccine candidate
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Transfer of Treasury Shares
AnnouncementREG - GlaxoSmithKline PLC - Benlysta approved in China for Lupus Nephritis
Announcement